Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice. (Q37957629)
scientific article published on February 2012
Language:
(P31) (Q13442814)
(P50) (Q71459053)
(P304) 59-69
(P407) (Q1860)
(P433) 1
(P478) 14
(P577) Wednesday, February 1, 2012
(P1433) (Q26842345)
(P1476) "Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice" (language: en)
(P2093) Harald Sourij
(P2860) (Q33945937)
(Q34437323)
(Q43584208)
(Q34370790)
(Q44745053)
(Q53759915)
(Q44671845)
(Q40637398)
(Q22250883)
(Q34686089)
(Q34985342)
(Q29619886)
(Q34461583)
(Q46313326)
(Q33834724)
(Q45290782)
(Q42957422)
(Q33600858)
(Q57419723)
(Q83512359)
(Q51581141)
(Q84299637)
(Q80768372)
(Q37240896)
(Q37794119)
(Q35044604)
other details
description scientific article published on February 2012

External Links